Inflammation, immunity, vaccines for Helicobacter infection

Helicobacter

Volumn 11, Issue SUPPL.1, 2006, Pages 21-26

  Chmiela, Magdalena ^a   Michetti, Pierre ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Helicobacter pylori; Host response; Inflammation; Vaccines

Indexed keywords

BACTERIAL VACCINE;

ANIMAL; CELL LINE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; MOUSE; PATHOGENICITY; PATHOPHYSIOLOGY; REVIEW; STOMACH MUCOSA;

ANIMALS; BACTERIAL VACCINES; CELL LINE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MICE;

EID: 34250310184     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1478-405X.2006.00422.x     Document Type: Article

References (58)

1. Ernst PB, Peura DA, Crowe SE. The translation of Helicobacter pylori basic research to patient care. Gastroenterology 2006;130:188-206.
2. Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of Nod1 and Nod2. Nat Rev Immunol 2006;6:9-20.
3. Portal-Celhay C, Perez-Perez GI. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci (Lond) 2006;110:305-14.
4. Terry K, Williams SM, Connolly L, Ottemann KM. Chemotaxis plays multiple roles during Helicobacter pylori animal infection. Infect Immun 2005;73:803-11.
5. McGee DJ, Langford ML, Watson EL, Carter JE, Chen YT, Ottemann KM. Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infect Immun 2005;73:1820-7.
6. Olfat FO, Zheng Q, Oleastro M, et al. Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol Med Microbiol 2005;44:151-6.
7. Walz A, Odenbreit S, Mahdavi J, Boren T, Ruhl S. Identification and characterization of binding properties of Helicobacter pylori by glycoconjugate arrays. Glycobiology 2005;15:700-8.
8. Kanbay M, Gur G, Arslan H, Yilmaz U, Boyacioglu S. The relationship of ABO blood group, age, gender, smoking, and Helicobacter pylori infection. Dig Dis Sci 2005;50:1214-7.
9. Marques T, David L, Reis C, Nogueira A. Topographic expression of MUC5AC and MUC6 in the gastric mucosa infected by Helicobacter pylori and in associated diseases. Pathol Res Pract 2005;201:665-72.
10. Miller-Podraza H, Lanne B, Angstrom J, et al. Novel binding epitope for Helicobacter pylori found in neolacto carbohydrate chains: structure and cross-binding properties. J Biol Chem 2005;280:19695-703.
11. Kim SG, Kim JS, Kim JM, Chae Jung H, Sung Song I. Inhibition of proinflammatory cytokine expression by NF-kappaB (p65) antisense oligonucleotide in Helicobacter pylori-infected mice. Helicobacter 2005;10:559-66.
12. Hirata Y, Ohmae T, Shibata W, et al. MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells. J Immunol 2006;176:3796-803.
13. Beswick EJ, Das S, Pinchuk IV, et al. Helicobacter pylori-induced IL-8 production by gastric epithelial cells up-regulates CD74 expression. J Immunol 2005;175:171-6.
14. Yoshino N, Ishihara S, Rumi MA, et al. Interleukin-8 regulates expression of Reg protein in Helicobacter pylori-infected gastric mucosa. Am J Gastroenterol 2005;100:2157-66.
15. Smith MF Jr, Novotny J, Carl VS, Comeau LD. Helicobacter pylori and Toll-like receptor agonists induce syndecan-4 expression in an NF-kappaB-dependent manner. Glycobiology 2006;16:221-9.
16. Brandt S, Kwok T, Hartig R, Konig W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA 2005;102:9300-5.
17. Dommett R, Zilbauer M, George JT, Bajaj-Elliott M. Innate immune defence in the human gastrointestinal tract. Mol Immunol 2005;42:903-12.
18. Boughan PK, Argent RH, Body-Malapel M, et al. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J Biol Chem 2006;281:11637-48.
19. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005;17:338-44.
20. Kelly D, Conway S. Bacterial modulation of mucosal innate immunity. Mol Immunol 2005;42:895-901.
21. Ferrero RL. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol Immunol 2005;42:879-85.
22. Basak C, Pathak SK, Bhattacharyya A, Pathak S, Basu J, Kundu M. The secreted peptidyl prolyl cis,trans-isomerase HP0175 of Helicobacter pylori induces apoptosis of gastric epithelial cells in a TLR4- and apoptosis signal-regulating kinase 1-dependent manner. J Immunol 2005;174:5672-80.
23. Rudnicka A, Chmiela M. Inflammation and host immune response in Helicobacter pylori infections. Cur Trends Immunol 2004;6:1-19.
24. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005;3:36-46.
25. Briede JJ, Pot RG, Kuipers EJ, van Vliet AH, Kleinjans JC, Kusters JG. The presence of the cag pathogenicity island is associated with increased superoxide anion radical scavenging activity by Helicobacter pylori. FEMS Immunol Med Microbiol 2005;44:227-32.
26. Wang G, Conover RC, Olczak AA, Alamuri P, Johnson MK, Maier RJ. Oxidative stress defense mechanisms to counter ironpromoted DNA damage in Helicobacter pylori. Free Radic Res 2005;39:1183-91.
27. Wang G, Alamuri P, Humayun MZ, Taylor DE, Maier RJ. The Helicobacter pylori MutS protein confers protection from oxidative DNA damage. Mol Microbiol 2005;58:166-76.
28. Basak C, Pathak SK, Bhattacharyya A, Mandal D, Pathak S, Kundu M. NF-kappaB- and C/EBPbeta-driven interleukin-1beta gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1beta release from Helicobacter pylori lipopolysaccharide-stimulated macrophages. J Biol Chem 2005;280:4279-88.
29. Slomiany BL, Slomiany A. Endothelin-1-dependent leptin induction in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun 2005;336:1106-11.
30. Nurgalieva ZZ, Conner ME, Opekun AR, et al. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun 2005;73:2999-3006.
31. Akhiani AA, Stensson A, Schon K, Lycke NY. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J Immunol 2005;174:8144-53.
32. Iizumi T, Yamanishi S, Kumagai Y, et al. Augmentation of Helicobacter pylori urease activity by its specific IgG antibody: implications for bacterial colonization enhancement. Biomed Res 2005;26:35-42.
33. Weyermann M, Borowski C, Bode G, et al. Helicobacter pylori-specific immune response in maternal serum, cord blood, and human milk among mothers with and without current Helicobacter pylori infection. Pediatr Res 2005;58:897-902.
34. + T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect Immun 2005;73:5612-9.
35. Guy B, Krell T, Sanchez V, Kennel A, Manin C, Sodoyer R. Do Th1 or Th2 sequence motifs exist in proteins? Identification of amphipatic immunomodulatory domains in Helicobacter pylori catalase. Immunol Lett 2005;96:261-75.
36. D'Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Helicobacter pylori, T cells and cytokines: the 'dangerous liaisons'. FEMS Immunol Med Microbiol 2005;44:113-9.
37. De Libero G, Moran AP, Gober HJ, et al. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 2005;22:763-72.
38. + T cells from H. pylori-infected individuals. Clin Immunol 2006;118:284-91.
39. + suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol Med Microbiol 2005;44:121-7.
40. Anderson KM, Czinn SJ, Redline RW, Blanchard TG. Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J Immunol 2006;176:5306-13.
41. Gerhard M, Schmees C, Voland P, et al. A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. Gastroenterology 2005;128:1327-39.
42. Aebischer T, Schmitt A, Walduck AK, Meyer TF. Helicobacter pylori vaccine development: facing the challenge. Int J Med Microbiol 2005;295:343-53.
43. Jeremy AH, Du Y, Dixon MF, Robinson PA, Crabtree JE. Protection against Helicobacter pylori infection in the Mongolian gerbil after prophylactic vaccination. Microbes Infect 2006;8:340-6.
44. Graham DY, Opekun AR, Osato MS, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 2004;53:1235-43.
45. Aebischer T, Bumann D, Epple HJ, et al. Development of a vaccine against Helicobacter pylori. Helicobacter 2005;10:547.
46. Nystrom J, Raghavan S, Svennerholm AM. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect 2006;8:442-9.
47. Avitzur Y, Galindo-Mata E, Jones NL. Oral vaccination against Helicobacter pylori infection is not effective in mice with Fas ligand deficiency. Dig Dis Sci 2005;50:2300-6.
48. Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori. Helicobacter 2006;11:113-22.
49. Shi T, Liu WZ, Gao F, Shi GY, Xiao SD. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection. Helicobacter 2005;10:71-9.
50. Velin D, Bachmann D, Bouzourene H, Michetti P. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 2005;129:142-55.
51. Aebischer T, Fischer A, Walduck A, et al. Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. FEMS Immunol Med Microbiol 2006;46:221-9.
52. Smythies LE, Novak MJ, Waites KB, Lindsey JR, Morrow CD, Smith PD. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection. Vaccine 2005;23:901-9.
53. Gu Q, Han N, Liu J, Zhu M. Cloning of Helicobacter pylori urease subunit B gene and its expression in tobacco (Nicotiana tabacum L.). Plant Cell Rep 2005;24:532-9.
54. Corthesy B, Boris S, Isler P, Grangette C, Mercenier A. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J Infect Dis 2005;192:1441-9.
55. Akhiani AA, Stensson A, Schon K, Lycke N. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization. Scand J Immunol 2006;63:97-105.
56. Kubota E, Joh T, Tanida S, et al. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit. Helicobacter 2005;10:345-52.
57. Bergonzelli GE, Granato D, Pridmore RD, Marvin-Guy LF, Donnicola D, Corthesy-Theulaz IE. GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect Immun 2006;74:425-34.
58. Shimosato T, Kimura T, Tohno M, et al. Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C.G-3' stem structure. Cell Microbiol 2006;8:485-95.